medmix AG (MEDX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, medmix AG (MEDX) has a cash flow conversion efficiency ratio of 0.086x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF37.40 Million ≈ $47.28 Million USD) by net assets (CHF432.80 Million ≈ $547.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
medmix AG - Cash Flow Conversion Efficiency Trend (2018–2025)
This chart illustrates how medmix AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MEDX total debt and obligations for a breakdown of total debt and financial obligations.
medmix AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of medmix AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhubo Design
SHE:300564
|
-0.028x |
|
Linhai Co Ltd
SHG:600099
|
0.435x |
|
Delta Plus Group SA
PA:ALDLT
|
0.047x |
|
Industrial Logistics Properties Trust
NASDAQ:ILPT
|
0.009x |
|
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952
|
0.023x |
|
Fittech Co Ltd
TW:6706
|
0.016x |
|
Daeduck Co. Ltd.
KO:008060
|
0.008x |
|
SGL Carbon SE
XETRA:SGL
|
0.033x |
Annual Cash Flow Conversion Efficiency for medmix AG (2018–2025)
The table below shows the annual cash flow conversion efficiency of medmix AG from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see MEDX market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF432.80 Million ≈ $547.18 Million |
CHF67.80 Million ≈ $85.72 Million |
0.157x | -19.19% |
| 2024-12-31 | CHF446.70 Million ≈ $564.75 Million |
CHF86.60 Million ≈ $109.49 Million |
0.194x | +63.94% |
| 2023-12-31 | CHF474.40 Million ≈ $599.77 Million |
CHF56.10 Million ≈ $70.93 Million |
0.118x | +25.41% |
| 2022-12-31 | CHF504.80 Million ≈ $638.20 Million |
CHF47.60 Million ≈ $60.18 Million |
0.094x | -42.33% |
| 2021-12-31 | CHF533.90 Million ≈ $674.99 Million |
CHF87.30 Million ≈ $110.37 Million |
0.164x | +7.74% |
| 2020-12-31 | CHF333.40 Million ≈ $421.51 Million |
CHF50.60 Million ≈ $63.97 Million |
0.152x | -49.73% |
| 2019-12-31 | CHF295.10 Million ≈ $373.09 Million |
CHF89.10 Million ≈ $112.65 Million |
0.302x | +8.88% |
| 2018-12-31 | CHF339.70 Million ≈ $429.47 Million |
CHF94.20 Million ≈ $119.09 Million |
0.277x | -- |
About medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through Healthcare; and Consumer and Industrial segments. The company offers dental products, including mixing tips and cartridges for various applications, such as prosthetics, restorations, anesthetics, and aesthetics; drug delivery devices that are used to inject fertility… Read more